THE SELECTION OF HARD CLINICAL ENDPOINTS VERSUS SURROGATE ENDPOINTS AS THE PRIMARY OUTCOME MEASURE IN MAJOR CARDIOVASCULAR CLINICAL TRIALS IS NOT INFLUENCED BY THE SOURCE OF FUNDING
2010 ◽
Vol 55
(10)
◽
pp. A132.E1236
Keyword(s):
2011 ◽
Vol 24
(5)
◽
pp. 689-697
◽
2012 ◽
Vol 9
(1S)
◽
pp. S45-S55
◽
Keyword(s):
2002 ◽
Vol 8
(1_suppl)
◽
pp. 40-51
◽
2015 ◽
Vol 76
(10)
◽
pp. e1320-e1323
◽
2010 ◽
Vol 16
(6)
◽
pp. 660-669
◽
2021 ◽
Vol 11
(3)
◽
pp. 167-173
2018 ◽
Vol 61
(4)
◽
pp. 811-819
◽
Keyword(s):
2002 ◽
Vol 8
(1)
◽
pp. 40-51
◽